BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 32992835)

  • 1. Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade.
    Zhao X; Shao C
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment.
    Luo R; Firat E; Gaedicke S; Guffart E; Watanabe T; Niedermann G
    Clin Cancer Res; 2019 Dec; 25(23):7243-7255. PubMed ID: 31506388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abscopal effect in radioimmunotherapy.
    Ashrafizadeh M; Farhood B; Eleojo Musa A; Taeb S; Rezaeyan A; Najafi M
    Int Immunopharmacol; 2020 Aug; 85():106663. PubMed ID: 32521494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature.
    Watanabe T; Firat E; Scholber J; Gaedicke S; Heinrich C; Luo R; Ehrat N; Multhoff G; Schmitt-Graeff A; Grosu AL; Abdollahi A; Hassel JC; von Bubnoff D; Meiss F; Niedermann G
    Cancer Immunol Immunother; 2020 Sep; 69(9):1823-1832. PubMed ID: 32350591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
    Liu Y; Dong Y; Kong L; Shi F; Zhu H; Yu J
    J Hematol Oncol; 2018 Aug; 11(1):104. PubMed ID: 30115069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment.
    Rückert M; Deloch L; Frey B; Schlücker E; Fietkau R; Gaipl US
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer.
    Dudzinski SO; Cameron BD; Wang J; Rathmell JC; Giorgio TD; Kirschner AN
    J Immunother Cancer; 2019 Aug; 7(1):218. PubMed ID: 31412954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune targets in the tumor microenvironment treated by radiotherapy.
    Ozpiskin OM; Zhang L; Li JJ
    Theranostics; 2019; 9(5):1215-1231. PubMed ID: 30867826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune mechanisms mediating abscopal effects in radioimmunotherapy.
    Rodriguez-Ruiz ME; Rodriguez I; Leaman O; López-Campos F; Montero A; Conde AJ; Aristu JJ; Lara P; Calvo FM; Melero I
    Pharmacol Ther; 2019 Apr; 196():195-203. PubMed ID: 30529041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8
    Wang H; Lin X; Luo Y; Sun S; Tian X; Sun Y; Zhang S; Chen J; Zhang J; Liu X; Liu H; Gong Y; Xie C
    Immunotherapy; 2019 Feb; 11(2):101-118. PubMed ID: 30511887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination PD-1 blockade and irradiation of brain metastasis induces an effective abscopal effect in melanoma.
    Pfannenstiel LW; McNeilly C; Xiang C; Kang K; Diaz-Montero CM; Yu JS; Gastman BR
    Oncoimmunology; 2019; 8(1):e1507669. PubMed ID: 30546944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies.
    Rodríguez-Ruiz ME; Rodríguez I; Mayorga L; Labiano T; Barbes B; Etxeberria I; Ponz-Sarvise M; Azpilikueta A; Bolaños E; Sanmamed MF; Berraondo P; Calvo FA; Barcelos-Hoff MH; Perez-Gracia JL; Melero I
    Mol Cancer Ther; 2019 Mar; 18(3):621-631. PubMed ID: 30683810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches.
    Tubin S; Yan W; Mourad WF; Fossati P; Khan MK
    Future Oncol; 2020 Jun; 16(16):1137-1151. PubMed ID: 32338046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors.
    Derer A; Frey B; Fietkau R; Gaipl US
    Cancer Immunol Immunother; 2016 Jul; 65(7):779-86. PubMed ID: 26590829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model.
    Wu L; Wu MO; De la Maza L; Yun Z; Yu J; Zhao Y; Cho J; de Perrot M
    Oncotarget; 2015 May; 6(14):12468-80. PubMed ID: 25980578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses.
    Caetano MS; Younes AI; Barsoumian HB; Quigley M; Menon H; Gao C; Spires T; Reilly TP; Cadena AP; Cushman TR; Schoenhals JE; Li A; Nguyen QN; Cortez MA; Welsh JW
    Clin Cancer Res; 2019 Dec; 25(24):7576-7584. PubMed ID: 31540976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation.
    Morisada M; Clavijo PE; Moore E; Sun L; Chamberlin M; Van Waes C; Hodge JW; Mitchell JB; Friedman J; Allen CT
    Oncoimmunology; 2018; 7(3):e1395996. PubMed ID: 29399393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation Therapy and Immune Modulation.
    Leeman JE; Schoenfeld JD
    Hematol Oncol Clin North Am; 2019 Apr; 33(2):233-248. PubMed ID: 30832997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances.
    Janopaul-Naylor JR; Shen Y; Qian DC; Buchwald ZS
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect.
    Rodríguez-Ruiz ME; Vanpouille-Box C; Melero I; Formenti SC; Demaria S
    Trends Immunol; 2018 Aug; 39(8):644-655. PubMed ID: 30001871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.